StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note published on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $11.68 on Monday. The stock’s 50-day moving average is $13.73 and its two-hundred day […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of NASDAQ:PIRS opened at $12.04 on Friday. Pieris Pharmaceuticals has a twelve month low of $10.89 and a […]
Investment analysts at StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS stock opened at $0.15 on Friday. Pieris Pharmaceuticals has a one year low […]
Equities research analysts at StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Get Free Report) in a report released on Sunday. The firm set a “hold” rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of PIRS stock opened at $0.15 on Friday. The business’s fifty day moving average price is […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Trading Up 8.3 % Shares of PIRS opened at $0.17 on Friday. The company’s fifty day simple moving average is $0.17 and its 200-day […]